Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Grapefruit Benefits

Most, But Not All, Canadians With Chronic Conditions Get Clinically Recommended Tests
Most Canadians with chronic conditions have a regular place of care, but there are some reported gaps in the management of their conditions according to a new study released today by the Canadian Institute for Health Information (CIHI). The study, Experiences With Primary Health Care in Canada, measures access to and quality of care from a patient perspective across Canada"s 10 provinces. The study is based on the responses of more than 11,000 people age 18 and older to Statistics Canada"s 2008 Canadian Survey of Experiences With Primary Health Care, which was jointly funded by CIHI and the Health Council of Canada.
generic viagra online
House Dems To Open Hearings Amid Controversy Over Finances, Public Plan
"House Democrats are pushing forward with a partisan health care bill even as a key Senate Democrat labors to achieve an elusive bipartisan compromise on President Barack Obama"s top legislative priority," The Associated Press reports. "The draft legislation, written without Republican help, would require all Americans to purchase health insurance and would put new requirements on employers, too." The House bill was unveiled last week and "is to be weighed in hearings beginning Tuesday."
News of the day
New Website Launches 1.2 Million Euro Project To Improve European Cancer Communications
An initiative to boost cancer prevention, treatment and care throughout Europe by improving communications within the cancer community kicks off today (Monday 20 July) with the launch of a new website: http://www.eurocancercoms.eu. The project will involve all those with an interest in cancer, from researchers and doctors to patients.
Health Insurance

AbbeyMoor Medical Receives FDA Approval For Design Improvements To The Spanner(TM) Prostatic Stent

AbbeyMoor Medical Inc., a developer and manufacturer of medical devices for the management and treatment of prostatic obstruction, announced that it has received PMA approval from the US Food and Drug Administration (FDA) for design changes to their flagship product, The Spanner(TM) Prostatic Stent. "These changes are aimed at further improving patient comfort over the current highly accepted levels," said Darren Cook, director of marketing with the company. "Our goal is to hear an even greater percentage of our patient"s state that they are not aware of the device"s presence." According to Mark Whalen, VP of product development with the company, "The approved changes to the device result in a significant increase in flexibility over the current Spanner design with no impact to the ease of delivery and removal of the device." The Spanner is a temporary prostatic stent designed to aid men who are experiencing difficulty in urination due to prostatic obstruction. Device placement can be performed in a physician office and does not require cystoscopy or anesthesia for placement. The Spanner is an alternative to indwelling catheterization, intermittent catheterization, or the use of a suprapubic tube in some patients. About AbbeyMoor Medical AbbeyMoor Medical is a privately held company that develops innovative medical devices focused on the management and treatment of male voiding dysfunction. The company"s initial focus is on the development and commercialization of The Spanner. AbbeyMoor Medical, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009